Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines.

Ramos KJ, Smith PJ, McKone EF, Pilewski JM, Lucy A, Hempstead SE, Tallarico E, Faro A, Rosenbluth DB, Gray AL, Dunitz JM; CF Lung Transplant Referral Guidelines Committee.

J Cyst Fibros. 2019 May;18(3):321-333. doi: 10.1016/j.jcf.2019.03.002. Epub 2019 Mar 27. Review.

2.

Cavitary lung nodules in a patient with prior squamous cell carcinoma of the submandibular gland.

Kulkarni HS, Rosenbluth DB.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1447-8. doi: 10.1164/rccm.201408-1493IM. No abstract available.

PMID:
25496104
3.

Gender differences in outcomes of patients with cystic fibrosis.

Harness-Brumley CL, Elliott AC, Rosenbluth DB, Raghavan D, Jain R.

J Womens Health (Larchmt). 2014 Dec;23(12):1012-20. doi: 10.1089/jwh.2014.4985.

4.

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, Quattrucci S, Rietschel E, Zeitlin PL, Barth J, Elfring GL, Welch EM, Branstrom A, Spiegel RJ, Peltz SW, Ajayi T, Rowe SM; Cystic Fibrosis Ataluren Study Group.

Lancet Respir Med. 2014 Jul;2(7):539-47. doi: 10.1016/S2213-2600(14)70100-6. Epub 2014 May 15.

5.

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, De Boeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, OrdoƱez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW.

Thorax. 2012 Jan;67(1):12-8. doi: 10.1136/thoraxjnl-2011-200393. Epub 2011 Aug 8.

6.

[18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation.

Chen DL, Bedient TJ, Kozlowski J, Rosenbluth DB, Isakow W, Ferkol TW, Thomas B, Mintun MA, Schuster DP, Walter MJ.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):533-9. doi: 10.1164/rccm.200904-0501OC. Epub 2009 Jul 2.

7.

Upregulation of elastin expression in constrictive bronchiolitis obliterans.

Shifren A, Woods JC, Rosenbluth DB, Officer S, Cooper JD, Pierce RA.

Int J Chron Obstruct Pulmon Dis. 2007;2(4):593-8.

8.

Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography.

Chen DL, Ferkol TW, Mintun MA, Pittman JE, Rosenbluth DB, Schuster DP.

Am J Respir Crit Care Med. 2006 Jun 15;173(12):1363-9. Epub 2006 Mar 16.

9.

Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR.

Atkinson RM, Lipuma JJ, Rosenbluth DB, Dunne WM Jr.

J Clin Microbiol. 2006 Mar;44(3):833-6.

10.

FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin.

Chen DL, Rosenbluth DB, Mintun MA, Schuster DP.

J Appl Physiol (1985). 2006 May;100(5):1602-9. Epub 2006 Jan 19.

11.

Lung function decline in cystic fibrosis patients and timing for lung transplantation referral.

Rosenbluth DB, Wilson K, Ferkol T, Schuster DP.

Chest. 2004 Aug;126(2):412-9.

PMID:
15302726
12.

Pulmonary hyalinizing granuloma associated with Aspergillus infection.

Pinckard JK, Rosenbluth DB, Patel K, Dehner LP, Pfeifer JD.

Int J Surg Pathol. 2003 Jan;11(1):39-42.

PMID:
12598920

Supplemental Content

Loading ...
Support Center